Below is an programme for the Virtual Conference, click on the session for more details, all timings are BST, please use to check your local timezone.

Please note this is subject to change.

Tues 20th April
Wed 21st April
Thurs 22nd April
10:00 - 10:15

Shareen Doak, Coordinator of PATROLS, Swansea University, UK

10:15 - 11:00
Exhibition and Posters Session 1
11:00 - 11:45
Keynote Speaker

Hazard identification of nanomaterials: in silico unravelling of descriptors for cytotoxicity and genotoxicity.
Professor Maria Dusinska, Norwegian Institute for Air Research, Norway


Chair: Shareen Doak, Coordinator of PATROLS, Swansea University, UK

11:45 - 12:00
Coffee break
12:00 - 13:10
Parallel Session 1

Parallel Session 1.1 – Hazard Characterisation of nanomaterials and advanced materials

Effect of Nrf2 deletion on inflammatory response in lung of female mice exposed to zinc oxide nanoparticles
Dr. Gaku Ichihara, Tokyo University Of Science, Japan

Indirect embryo-fetal risks of nanoparticles: Impact on human placental function, the release of placental signaling factors and subsequent alterations on angiogenic and neurodevelopmental processes
Ms Battuja Batbajar Dugershaw, Empa St. Gallen, Switzerland

Titanium dioxide nanomaterials- induced DNA damage in intestinal cells following simulated in vitro digestion
Dr Henriqueta Louro, Department of Human Genetics, National Institute of Health, Portugal

Dissecting nanoparticle specific key events orchestrated in the mouse lung for improved in vitro testing strategies
Dr. Carola Voss, Helmholtz Center Munich, Germany

Adverse Outcome Pathway development for assessment of lung carcinogenicity by nanomaterials
Dr. Penny Nymark, Karolinska Institute, Sweden

Assessment of Cytotoxicity of Metal Oxide Nanoparticles on the Basis of Physical-Chemical Parameters Immediately Available
Dr. Felice Simeone, Cnr-national Research Council Of Italy, Italy


Parallel Session 1.2 – Risk assessment of nanomaterials and advanced materials, and their governance

The GRACIOUS Framework – Grouping and Read-Across of Nanomaterials in order to streamline innovation and risk assessment
Prof Vicki Stone, Herior-Watt Univeristy, UK

The caLIBRAte nano-risk innovation governance framework and tools with demonstration of its use for risk management along a stage-gate innovation funnel.
Professor Keld Alstrup Jensen, National Research Centre for the Working Environment, Denmark

Decision Support System for risk assessment and management of nano(bio)materials used in medical devices and advanced therapy medicinal products
Phd Alex Zabeo, Greendecision, Italy

The Stakeholder engagement to structure the regulatory governance of nanomaterials
Professor Wilson Engelmann, University Of Vale Do Rio Dos Sinos, Brazil

DaNa4.0 – advanced materials knowledge base in a new outfit
Dr. Katja Nau & Dr. Christoph Steinbach, Karlsruhe Institute Of Technology, Germany


Parallel Session 1.3 – Hazard Characterisation & Ranking

Testing and Ranking the Reactivity and Solubility of Nano-and Micro-Size Materials’ in Different Cell Culture Media Using Sensor Dish Reader TM
Miss Amalie Kofoed Jørgensen, NFA, Denmark

Grouping nanoforms with differing organic surface treatments based on coating material biodegradation rates
Dr Richard Cross, UKCEH, UK

Predicting the hazardous potential of metallic nanomaterials in HepaRG cells using the Isalos Analytics Platform
Dr Anastasios Papadiamantis, NovaMechanics Ltd, Cyprus

A Systematic Approach to Investigate the Carrier Effect of Polycyclic Aromatic Hydrocarbons (PAHs) for Micro and Nano Polymer Particles (PPs)
Mr. Emeka Emecheta, German Federal Institute For Risk Assessment, Germany

Quaternary mixtures of TiO2NP, CeO2NP, arsenic, and mercury potentiate A549, HepG2 and SH-SY5Y cells cytotoxicity
Dr. Fernanda Rosário, National Institute Of Health Doutor Ricardo Jorge, Portugal

13:10 - 14:00
13:15 - 14:00
Exhibition and Posters Session 2
14:00 - 14:45
Keynote Speaker

Utilising integrated approaches to testing and assessment (IATAs) to make grouping decisions for nanomaterials
Dr Helinor Johnston, Heriot Watt University, UK


Chair: Shareen Doak, Coordinator of PATROLS, Swansea University, UK

14:45 - 15:00
Coffee break
15:00 - 16:10
Parallel Session 2

Parallel Session 2.1

Alternative methods for nanomaterial hazard testing

Chronic Inflammation Prediction for Inhaled Particles based on Nanomaterial Cycling and Quarantining in the Lung Epithelium
Prof. Janez Štrancar, Jozef Stefan Institute, Slovenia

Intestinal effects of engineered nanomaterials – advanced in vitro models vs. in vivo feeding studies
Dr. Angela Kämpfer, Iuf, Germany

Investigating protein-nanoparticle interactions in 3D models of the human bronchial epithelium for the long-term toxicity study of inhaled nanoparticles
Mr Daniel Sanchez-Guzman, Université De Paris-BFA, France

Implementing an alveolar in vitro co-culture model to predict the potential hazard of engineered nanomaterial (ENM) inhalation exposure using Adverse Outcome Pathways (AOPs).
Dr Kirsty Meldrum, Swansea University, UK

Grouping of nanoforms following oral ingestion: Development of an Integrated Approach to Testing and Assessment within The EU Project GRACIOUS
Dr Luisana Di Cristo, Istituto Italiano Di Tecnologia, Italy

Gut microbiome and plasma metabolome changes in rats after oral gavage of nanoparticles – sensitive indicators of possible adverse health effects
Dr. Daniela Hahn, Biomedical Technology Center, Germany

Developing Integrated Approaches for Testing and Assessment of nanobiomaterial safety following intravenous exposure
Ms Suzanne Gillies, Heriot-Watt University, UK


Parallel Session 2.2

Release and exposure to nanomaterials and advanced materials

Rat biodistribution of cerium dioxide and titanium dioxide nanomaterials after single and repeated inhalation exposure
Dr Ilse Gosens, RIVM, The Netherlands

Subcellular and intracellular dissolution of particulate and fibrous metal-based nanomaterials in pulmonary cell lines
Mrs Johanna Wall, Karlsruhe Institute of Technology, Germany

Focal accumulations of nanoparticles in remote organs: a quantitative LA-ICP-MS study
MSc Svenja Berit Seiffert, BASF SE, Germany

In vitro intestinal models for nanomaterial toxicity and translocation studies
Dr Victor Ude, Heriot-Watt Univeristy, UK

Integration of particle size distribution into material flow analysis of titanium dioxide
Ms Yuanfang Zheng, Empa, Switzerland

Physiologically Based Kinetic Modelling of cerium dioxide and titanium dioxide nanomaterials in rat after inhalation
Mr Jordi Minnema, RIVM, The Netherlands


Parallel Session 2.3

Environmental hazard characterisation

Acute ZnONP exposure induces oxidative stress responses in the olfactory sensory neurons and alters olfaction-mediated behaviour in zebrafish embryos
Dr. Aya Takesono, University of Exter, UK

Lipid and iron nanobiomaterials only produce toxic effects in fish cell lines after a long-term exposure
Dr. David Hernandez-Moreno, National Institute for Agricultural and Food Research and Technology (INIA), Spain

Bioaccumulation potential of CuO nanoparticles following dietary exposure to rainbow trout
Dr Judit Kalman, National Institute for Agricultural and Food Research and Technology (INIA), Spain

Quantification of CeO2 nanoparticle uptake in algal cells using single cell ICP-MS and ICP-TOFMS
Dr Aiga Mackevica, Technical University Of Denmark, Denmark

Eco-friendly preparation of high-quality reduced graphene oxide via sonoluminescence with a TiO2 photocatalyst
A Young Lee, Korea Research Institute Of Standards And Science, South Korea


09:30 - 09:35

Chair: Vicki Stone, Coorinator of GRACIOUS, Heriot-Watt University, UK

09:35 - 10:30
Exhibition and Posters Session 3
10:30 - 11:15
Keynote Speaker

Unmasking the Surface Effect: A Superficial View of Nanotoxicology
Prof. Bengt Fadeel, M.D., Ph.D, Karolinska Institutet, Sweden


Chair: Vicki Stone, Coorinator of GRACIOUS, Heriot-Watt University, UK

11:15 - 12:25
Parallel Session 3

Parallel Session 3.1

Risk assessment and governance

The NanoInformaTIX platform
Dr. Gianpietro Basei, GreenDecision S.r.l., Italy

Occupational risk assessment of nano-biomaterials used in medical devices and advanced therapy medicinal products and its application to a case study using the BIORIMA Decision Support System
Ms. Virginia Cazzagon, University Ca’ Foscari Of Venice, Italy

Simulation of the Dose-response relationships of metal and metal oxide nanomaterials
Dr. Warisa Bunmahotama, Institute of Environmental Sciences (CML), Leiden University, The Netherlands

Quality of nanoplastics and microplastics ecotoxicity studies: refining nanomaterial reporting quality criteria
Dr. Dana Kühnel, Helmholtz-centre For Environmental Research – Ufz, Germany

Going beyond Microplastics: Food Safety Risk Assessment Approaches for Submicron- and Nano-sized Plastic Particles
Dr. Holger Sieg, German Federal Institute For Risk Assessment, Germany


Parallel Session 3.2

Alternative methods for nanomaterial hazard testing

In vitro-in vivo correlations of pulmonary toxicity caused by MWCNT
Mr. Emilio Di Ianni, National Research Centre For The Working Environment, Denmark

Transcriptomic-based and AOP-informed structure-activity relationships to predict adverse outcomes induced by nanomaterials.
Dr. Karolina Jagiello, QSAR Lab, Poland

Towards a better understanding of occupational exposures: In vitro macrophage systems for repeated nanomaterial exposure studies
Mrs Anaëlle Torres, Cea/irig/diese/lcbm/promd, France

Neutrophil responses to nanomaterials in vitro: comparing primary human neutrophils with the HL-60 cell line
Ms Suzanne Gillies, Heriot-Watt University, UK

An interlaboratory comparison study upon particle deposition and exposure effects using an air-liquid interface lung cell model
Dr Hedwig Braakhuis & Dr Rob Vandebriel, National Institute for Public Health & Environment, The Netherlands

CoDo – a combined in vitro-in vivo dosimetry model enabling the comparison of in vitro doses and exposure levels for nanomaterials
Ms Daina Romeo, Empa, Switzerland


Parallel Session 3.3

Environmental hazard characterisation

Long-term impacts of nTiO2 and nTiO2-coated carbendazim on zooplankton and macroinvertebrate communities (in naturally assembled model ecosystems)
Msc. Tom Nederstigt, Leiden University, The Netherlands

Modeling local nanobiomaterial release hotspots in the environment
Mrs Marina Hauser, Empa, Switzerland

Effects of suspended titanium dioxide nanoparticles on microbiota of early-life stage zebrafish
MSc. Bregje Brinkmanna, Leiden University, Institute of Environmental Sciences, The Netherlands

Uptake of manufactured CeO2 NPs by freshwater shrimps – A dual-radiolabelling study
Dr. Stefan Schymura, HZDR – Institute of Resource Ecology, Germany

Dietary exposure to TiO2 and silver nanoparticles in zebrafish (Danio rerio): Evaluating the bioaccumulation and depuration kinetics using single particle-ICP-MS analysis
Jung Yang, Department of Environment Engineering, National Cheng Kung University, Taiwan

Tracing the environmental and biological fate of nanomaterials: application of isotope labelling and synchrotron radiation-based techniques
Mr Peng Zhang, University Of Birmingham, UK

12:25 - 12:40
Coffee break
12:40 - 13:25
Keynote Speaker

Physiologically Anchored Tools for Realistic nanomaterial hazard aSsessment (PATROLS): establishing advanced ecotoxicity testing and cross-species models
Prof. Dr. Martina Vijver, Leiden University, The Netherlands


Chair: Vicki Stone, Coorinator of GRACIOUS, Heriot-Watt University, UK

13:25 - 14:15
13:30 - 14:15
Exhibition and Posters Session 4
14:15 - 15:25
Parallel Session 4

Parallel Session 4.1

Hazard Characterisation of nanomaterials and advanced materials

Development of Liver Carcinoma Biomarker Panel in 3D HepG2 Liver Spheroids Following Nanomaterial Exposure
Miss Gillian Conway, Swansea University, UK

Predicting the hazardous potential of metallic nanomaterials in HepaRG cells using the Isalos Analytics Platform
Dr Anastasios Papadiamantis, NovaMechanics Ltd, Cyprus

Deducing the impact of carbon-based engineered nanomaterials at occupationally relevant exposure concentrations upon the innate immune system in vitro
Dr Martin Clift, Swansea University, UK

Real time in vivo investigation early alveolar neutrophil dynamics during ventilator-assisted nanoparticle inhalation
M.Med. Qiongliang Liu & Prof. Dr. rer. nat. Markus Rehberg, Institute Of Lung Biology And Diseases(iLBD)/ Comprehensive Pneumology Center (CPC), Helmholtz Zentrum München, Germany

Exposure of mouse monocyte/macrophage (J774) & human lung epithelial (A459) cells to ZnO nanoforms, and in vitro cytotoxic responses
Dr Premkumari Kumarathasan, Department Of Health, Canada


Parallel Session 4.2

Hazard Characterisation of nanomaterials and advanced materials

Study on dietary bioaccumulation of titanium dioxide nanoparticles by turbot
Ms Monica Quarato & Dr Begoña Espiña, International Iberian Nanotechnology Laboratory, Portugal

Exposure to TiO2 NPs and ZnO NPs induce alterations in metabolic pathways leading to lipid synthesis in the A549 cells
Mr Arturo Jimenez-Chavez, Centro de Investigación y de Estudios Avanzados del IPN, Mexico

Occupational Inhalation Exposures to Nanoparticles at Six Singapore Printing Centers
Dr Magdiel Inggrid Setyawati, Nanyang Technological University, Singapore

Atomizer Differential Mobility Analyzer Hyphenated with Single Particle Inductively Coupled Plasma-Mass Spectrometry (DMA-spICP-MS): Development and Performance Evaluation
Mr. Yi Chin Hsieh, National Cheng Kung University, Taiwan


Parallel Session 4.3

Hazard assessment and making the most of complex data sets

Similarity of nanoforms for grouping purposes: Methods to compare the biological behavior of nanoforms
Dr. Gemma Janer & Dr. Wendel Wohlleben, Basf Se, Germany

Similarity assessment of metallic nanoparticles
Prof.dr. Willie Peijnenburg, Rivm, The Netherlands

Meta-analysis of animal studies for assessing the genotoxicity of 26 different engineered nanoparticles
Dr. Daniela Hahn, Biomedical Technology Center, Germany

In vitro toxicity of synthetic amorphous nano-silica – investigating the role of surface silanol groups
Miss Polly Cooper, Institute of Occupational Medicine, UK

Exploring the biocompatibility, efficacy and biodegradability of carbohydrate-derived carbon nanoparticles for photo-thermal therapy of lung cancer
Ph.D. Ida Kokalari, University Of Turin, Italy

Pulmonary effects of Fe3O4-PEG-PLGA nanoparticles in human bronchial epithelial cells and in wild type and Nrf2 knockout mice following pharyngeal aspiration
Ms Harue Sato, Tokyo University of Science, Japan

15:25 - 15:40
Coffee break
15:40 - 16:25
Keynote Speaker

An EU regulatory approach to address the risk of nanomaterials under REACH
Dr. Amaia Rodriguez, European Chemicals Agency, Finland


Chair: Vicki Stone, Coorinator of GRACIOUS, Heriot-Watt University, UK

09:00 - 09:05

Chair: Lang Tran, Coordinator of BIORIMA, IOM, UK

09:05 - 09:50
Exhibition and Posters Session 5
09:50 - 10:35
Keynote Speaker

In vivo Transportation and Bioavailability of MoS2 Nanomaterials Bridged by Protein Corona
Chunying Chen, National Center for Nanoscience and Technology of China


Chair: Lang Tran, Coordinator of BIORIMA, IOM, UK

10:35 - 10:50
Coffee break
10:50 - 12:00
Parallel Session 5

Parallel Session 5.1

Hazard Characterisation of nanomaterials and advanced materials & Alternative methods for nanomaterial hazard testing

Similarity by Reactivity Determined by EPR, DCFH, FRAS and In Vitro Assays
Dr. Didem Ag Seleci, BASF, Germany

A similarity testing computational workflow for grouping nanoforms
Dr Georgia Tsiliki, ATHENA RC, Greece

OECD approval is not the end of the story – are existing test methods (OECD 442ff) applicable to nanomaterials?
Dr. Barbara Birk & Dr. Robert Landsiedel, Basf Se, Germany

Unraveling the mode of action of nanomaterials from the interpretation of proteomics experiments
Dr. Veronica Dumit, Bundesinstitut Für Risikobewertung (bfr), Germany

A battery of tests for nanobiomaterial high throughput cyto- and genotoxicity testing
Dr Marie Carriere, Cea, France

Predicting In Vitro Neurotoxicity Induced by Nanoparticles Using Machine Learning
Dr Irini Furxhi, Transgero, Ireland


Parallel Session 5.2

Hazard Characterisation of nanomaterials and advanced materials

Hazard Assessment in Nanotoxicology – the CoCoN-Database Science Approach
Prof. em. Dr. Harald F. Krug, NanoCase GmbH, Switzerland

Advancing Adverse Outcome Pathway (AOP) Development for Nanomaterial Risk Assessment and Categorization – Outcomes of an OECD WPMN Project
Dr. James Ede, Vireo Advisors, Canada

Standardisation of the in vitro micronucleus assay for use in nanosafety
Dr Michael Burgum, Swansea University, UK

The effect of silica nanoparticles on blood-testis barrier
Dr. Kazuma Higashisaka, Osaka University, Japan

Unraveling diesel exhaust particle translocation and impact on extracellular vesicle signaling at the human placenta ex vivo
Phd Leonie Aengenheister, Empa, Switzerland


Parallel Session 5.3

Safe(r) by design (SbD) of nanomaterials and advanced materials (include Risk Assessment)

Safe-by-design alternatives for the production of Ag-based wound dressings
Dr Magda Blosi, Cnr Istec, Italy

Computing some advanced descriptors for nanomaterials toxicity: the case of TiO2 nanoparticles employing Molecular Dynamics
Dr Giulia Mancardi, Politecnico Di Torino, Italy

A multicriteria decision tool to address Safe-by-Design solutions for nanomaterials and nano-enabled products
PhD Massimo Perucca, Project HUB360, Italy

Effect of surface composition on the pulmonary toxicity of cellulose nanofibrils
Dr Julia Catalán, Finnish Institute Of Occupational Health, Finland

Environmental Health and Safety of Cellulose Nanocrystals
Dr. Kimberly Ong, Vireo Advisors, Canada

12:00 - 12:15
Coffee break
12:15 - 13:00
Keynote Speaker

Understanding material specific cell-particle interactions in the lung for the prediction of chronic health effects of inhaled nanomaterials
Dr Tobias Stoger, Helmholtz Zentrum München, Germany


Chair: Lang Tran, Coordinator of BIORIMA, IOM, UK

13:00 - 13:30
Award Ceremony & Closing of Conference
Select date to see events.